ClinicalTrials.Veeva

Menu

Drum-Assisted Therapy for Native Americans

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Terminated

Conditions

Substance Use Disorders

Treatments

Behavioral: Treatment-As-Usual
Behavioral: DARTNA

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Drum-Assisted Recovery Therapy for Native Americans (DARTNA) is an R-21 NIH/NCCAM-funded study aimed to complete the development and pilot a new substance abuse treatment protocol utilizing drumming for American Indians/Alaska Natives with substance use disorders. The study includes activities to complete the protocol, followed by a randomized-controlled clinical trial.

Full description

During year 1, this study consists of a series of focus groups conducted among American Indians/Alaska Natives with substance use disorders, providers serving AI/ANs with substance use disorders, and a Community Advisory Board. These focus groups are conducted in order to obtain feedback with regard to the initial DARTNA treatment protocol. These focus groups are then followed by a pretest of DARTNA among 10 AI/ANs with substance use disorders followed by a series of focus groups to finalize the development of DARTNA. During year 2, a randomized controlled will be conducted among 30 AI/ANs receiving the DARTNA treatment protocol vs. 30 AI/ANs receiving treatment-as-usual at United American Indian Involvement, Inc. in Los Angeles.

Enrollment

10 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR; American Psychiatric Association, 2000) criteria of current alcohol or drug abuse or dependence
  • self-identifying as at least ¼ American Indian/Alaska Native heritage
  • seeking treatment for alcohol or drug abuse
  • being at least 18 years old. Clients will be assessed for suitability for outpatient treatment.

Exclusion criteria

  • have a psychiatric conditions that is not suitable for outpatient treatment (e.g., if they require inpatient rehabilitation treatment, have significant psychiatric disorders, require medical detoxification, or have significant medical problems)
  • have a current suicidal ideation/plan as assessed by the ASI or BSI
  • are mandated by the court to obtain treatment for substance abuse where such mandate requires the results of urine toxicology tests to be reported to the court
  • expectation that the participant will fail to complete the study protocol due to probable incarceration or relocation from the clinic area.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Treatment-As-Usual
Active Comparator group
Description:
Substance Abuse treatment typically received
Treatment:
Behavioral: Treatment-As-Usual
DARTNA
Experimental group
Description:
12-week DARTNA program
Treatment:
Behavioral: DARTNA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems